11/20/2018
The U.S. Court of Appeals for the Federal Circuit lifted a preliminary injunction that blocked it from selling the generic, reversing a lower court's judgement
11/20/2018
The acquisition will add early stage API and finished dosage form development and testing services to its global contract development and manufacturing network
11/19/2018
The FDA has declined to approve an oral film male enhancement drug developed by Aquestive Therapeutics.
11/19/2018
Novartis has spent nearly $15 billion in the past year to step up its presence in cutting-edge areas of medical research, including gene therapy and radiopharmaceuticals.
11/15/2018
AbbVie has agreed to collaborate with Mission Therapeutics to develop deubiquitylating enzymes (DUBs) for the potential treatment of Alzheimer's disease and Parkinson's disease.
11/15/2018
Bristol-Myers Squibb announced it will lay off close to 20 percent of its Tampa location workforce in January 2019.
11/15/2018
South Korea’s top financial regulator said Samsung BioLogics had intentionally breached accounting rules ahead of its 2016 listing, leading to a suspension in trading of the biotech’s shares, a review of its listing status and the request that the CEO is fired.
11/14/2018
Lyrica has officially fallen off the patent cliff in Britain.
11/14/2018
Merck’s top-selling Keytruda has proven effective in yet another phase 3 trial, this time with esophageal cancer.
